PDL BioPharma PDLI
-
Cramer's Lightning Round - SunPower Has Staying Power (5/15/13)
… Solar is turning positive. SunPower has staying power. I like First Solar more. It has true profitability." PDL BioPharma ( PDLI ): "It is a spec, but I like this one." Ford ( F ) : "I think Europe is bottoming. Ford is a buy." Berkshire …
-
PDL BioPharma CEO Discuses Q1 2013 Results - Earnings Call Transcript
PDL BioPharma Inc. ( PDLI ) Q1 2013 Earnings Call May 9 ..... Good afternoon and welcome to the PDL BioPharma ’s First Quarter 2013 Earnings Conference ..... seekingalpha.com/article/1421991- pdl - biopharma -ceo-discuses-q1-2013-results …
-
PDL Biopharma ( PDLI ): Q1 EPS of $0.36 in line. Revenue of $91.8M (+19% Y/Y) beats by $110K. (PR). Shares +2% AH.
PDL Biopharma ( PDLI ): Q1 EPS of $0.36 in line. Revenue of $91.8M (+19% Y/Y) beats by $110K . ( PR ). Shares +2% AH. Post your comment!
-
Whisper Number Impact: Earnings Preview For PDL BioPharma
By WhisperNumber : PDL BioPharma ( PDLI ) is expected to report earnings after the close on Thursday ..... Whisper numbers range from a low of $0.40 to a high of $0.45. PDLI has a 63% positive surprise history, having topped the whisper …
-
PDLI
Looking for opinions on PDLI . Good purchase price? Is the dividend safe? What happens when the patents expire in 2014? Thanks. Roger
-
3 Healthcare Stocks With Greater Than 4% Dividend Yields To Inject Life Into Your Portfolio
By Black Coral Research : Big pharmaceutical stocks have been losing their shine among investors seeking high-growth investments. The sector is witnessing fewer new blockbuster drugs along with the headwinds from efforts to limit healthcare spending globally. Despite this, the pharma sector ...
-
Rovi Corporation: A Case Study In The Value Of Intellectual Property
… STRFKR record, to the humanization of antibodies patents (known as the Queen, et. al. patents) awarded to PDL BioPharma ( PDLI ). Even this article is IP: it is my original work, and I have granted its publisher an exclusive license to …
-
PDL BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript
PDL BioPharma , Inc. ( PDLI ) Q4 2012 Earnings Conference Call ..... and gentlemen and welcome to the PDL BioPharma ’s Fourth Quarter 2012 Earnings Conference ..... seekingalpha.com/article/1241781- pdl - biopharma -s-ceo-discusses-q4-2012 …
-
PDL BioPharma Inc. ( PDLI ): Q4 EPS of $0.34 beats by $0.03. Revenue of $86M in-line. (PR)
PDL BioPharma Inc. ( PDLI ): Q4 EPS of $0.34 beats by $0.03 . Revenue of $86M in-line. ( PR ) Post your comment!
-
Notable earnings after Friday’s close: [[ PDLI ]], [[STEC]], [[VECO]], [[VNR]]
Notable earnings after Friday’s close: PDLI , STEC , VECO , VNR Post your comment!